The Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms

Mainak Mazumdar ()
Additional contact information
Mainak Mazumdar: Centre De Sciences Humaines (CSH)

Chapter Chapter 3 in Performance of Pharmaceutical Companies in India, 2013, pp 45-71 from Springer

Abstract: Abstract Using the non parametric approach of Data Envelopment Analysis (DEA) this chapter examines firm’s heterogeneity in the Indian pharmaceutical industry by measuring their input and output efficiencies. The analysis establishes that even though firms have been able to make efficient use of inputs like labor and raw material, the output efficiency reveals a declining trend. The phenomenon can be attributed to differences in the size of firms and the presence of economies of scale in production. Further analysis reveals the importance of firm specific factors like its strategies and structure for variation in output efficiency. We find that firms that are vertically integrated with down-stream raw-material industry are more efficient. We also find that R&D is a possible strategic option for only the larger sized firms to gain higher efficiency.

Keywords: Data Envelopment Analysis; Capital Stock; Efficiency Score; Output Efficiency; Inefficient Firm (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-7908-2876-4_3

Ordering information: This item can be ordered from
http://www.springer.com/9783790828764

DOI: 10.1007/978-3-7908-2876-4_3

Access Statistics for this chapter

More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().